Skip to main content
. 2010 Aug 18;26(2):388–396. doi: 10.1002/jbmr.221

Table 2.

Potential Determinants of Whole-Body BMD: Analysis by Gender

Male Female


Variable Univariate β estimate Multivariatea β estimate Univariate β estimate Multivariateb β estimate
Lean body mass (kg) 0.005*** 0.006*** 0.007*** 0.006***
Age (per increase of 5 years) 0.003 0.002 −0.03** −0.02***
Race (non-African American/African American) 0.04 0.04 −0.18*** −0.14***
Methadone 0.03 NS −0.05* −0.05***
HIVc 0.02 NS 0.04 0.03
Smokingd 0.02 NS 0.04 NS
Alcohole NS NS
 0 (no use) Ref Ref
 1 (<3 drinks/day) 0.03 0.05*
 2 (≥3 drinks/day) 0.007 0.01
Drug usef NS NS
 0 (no use) Ref Ref
 1 (<3 times/week) 0.005 0.01
 2 (≥3 times/week) 0.02 0.05
Hypogonadalg/menopausalh 0.01 NS −0.1*** NS
Hepatitis Ci 0.005 NS 0.02 NS
Fat body mass (kg) <0.01 NS < 0.01* NS
BMI (kg/m2) 0.007** NS 0.005** (Not included)
DHEA (tertiles)j NS NS
 1 Ref Ref
 2 0.04 0.05
 3 0.0004 0.07**
Estradiol (tertiles)j NS NS
 1 Ref Ref
 2 0.003 0.04
 3 0.02 0.08**
IL-6 (tertiles)j NS NS
 1 Ref Ref
 2 0.006 0.01
 3 0.004 0.02
CRP (tertiles)j NS NS
 1 Ref Ref
 2 0.03 0.03
 3 0.007 0.03
TNF-α (tertiles)j NS NS
 1 Ref Ref
 2 0.03 0.03
 3 0.006 0.03

NS = nonsignificant.

Note: Items in boldface denote significant p values:

*

p < .05.

**

p < .01.

***

p < .0001.

a

Final model R2 value = 0.12, R2 adjusted = 0.1, p < .0001, n = 186.

b

Final model R2 value = 0.38, R2 adjusted = 0.36, p < .0001, n = 150.

c

Self-report, HIV+ by testing, or history of past or present use of antiretroviral therapy.

d

Determined by answering yes to having smoked cigarettes in the past 6 months (irrespective of quantity).

e

Equivalent of 1 drink is 8 fluid ounces of beer or wine, 4 fluid ounces of liquor or malt, and 1 fluid ounce of vodka.

f

Includes marijuana, crack/freebase, cocaine (snorting, injection), speedball (injection), heroin (smoking, snorting, injection), and street methadone in the past 6 months.

g

Defined as having free testosterone level < 52 pg/mL or currently on testosterone-replacement therapy.

h

Defined as having an FSH level > 50 mIU/mL, age ≥ 51 years, or an FSH level >30 and ≤50 mIU/mL and answered yes to having gone through menopause.

i

Self-report.

j

Obtained by plotting continuous lab values, 0 representing the lowest tertile, 1 the middle tertile, and 2 the highest tertile.